Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
MISONIX INC (MSON) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/29/2021 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Certificate of Formation of Merger Sub II",
"Limited Liability Company Agreement of Misonix, LLC"
10/26/2021 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus"
10/18/2021 8-K Other Events  Interactive Data
09/02/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
07/29/2021 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements...
Docs: "Agreement and Plan of Merger, by and among Misonix, Bioventus, First Merger Sub and Second Merger Sub",
"Bioventus Voting and Support Agreement, by and among Misonix and the Bioventus Supporting Stockholders",
"Form of Misonix Voting and Support Agreement, by and among Bioventus Inc. and the Misonix Supporting Stockholders",
"Norberto Aja, Jennifer Neuman",
"Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix The Combination Further Differentiates Bioventus' Product Portfolio and Accelerates Its Revenue Growth",
"Investor Presentation",
"Investor Presentation Q&A"
06/23/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
02/04/2021 8-K Quarterly results
02/04/2021 8-K Quarterly results
12/17/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "RECITALS"
11/05/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Misonix, Inc. and Subsidiaries Condensed Consolidated Statements of Operations For the three months ended September 30, 2020 2019 Revenue $ 17,735,342 $ 11,145,922 Cost of revenue 5,110,601 3,236,647 Gross profit 12,624,741 7,909,275 Operating expenses: Selling expenses 10,969,678 5,200,582 General and administrative expenses 4,452,328 4,207,807 Research and development expenses 1,250,174 771,411 Total operating expenses 16,672,180 10,179,800 Loss from operations Other income : Interest income 1,092 18,877 Interest expense Other 1,417 Total other income Loss from operations before income taxes Income tax benefit - 4,085,000 Net income $ $ 1,796,492 Net income per share: Basic $ $ 0.18 Diluted $ $ 0.17 Weighted average shares - Basic 17,213,686 9,686,402 Weighted average shares - Dilute..."
10/06/2020 8-K Quarterly results
09/03/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "MISONIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2020 RESULTS FARMINGDALE, N.Y., September 3, 2020 — Misonix, Inc. , a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2020 fourth quarter and full fiscal year ended June 30, 2020 as summarized below:"
07/10/2020 8-K Quarterly results
07/01/2020 8-K Quarterly results
07/01/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
04/15/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note, by and between Misonix, Inc. and JPMorgan Chase Bank, N.A"
04/02/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Use of Non-GAAP Financial Measures"
02/05/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Misonix, Inc. and Subsidiaries Condensed Consolidated Statements of Operations For the three months ended For the six months ended December 31, December 31, 2019 2018 2019 2018 Revenues Product $ 19,721,986 $ 10,176,453 $ 30,867,908 $ 19,537,617 Total revenue 19,721,986 10,176,453 30,867,908 19,537,617 Cost of revenue 5,945,108 3,048,079 9,181,755 5,798,622 Gross profit 13,776,878 7,128,374 21,686,153 13,738,995 Operating expenses: Selling expenses 11,800,565 4,800,643 17,001,147 9,535,648 General and administrative expenses 5,149,715 2,347,184 9,357,522 5,530,568 Research and development expenses 1,087,449 839,219 1,858,860 2,143,984 Total operating expenses 18,037,729 7,987,046 28,217,529 17,210,200 Loss from operations Other income : Interest income 5,293 17,242 24,170 37,056 Interest..."
01/27/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and among the Company and Canaccord Genuity LLC, acting as representative of the several underwriters named therein",
"Opinion of Jones Day"
01/16/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Press Release"
12/30/2019 8-K Quarterly results
12/04/2019 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from BDO USA, LLP"
11/07/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Misonix, Inc. and Subsidiaries Condensed Consolidated Statements of Operations For the three months ended September 30, 2019 2018 Revenues Product $ 11,145,922 $ 9,361,164 Total revenue 11,145,922 9,361,164 Cost of revenue 3,236,647 2,750,543 Gross profit 7,909,275 6,610,621 Operating expenses: Selling expenses 5,200,582 4,735,005 General and administrative expenses 4,207,807 3,183,384 Research and development expenses 771,411 1,304,766 Total operating expenses 10,179,800 9,223,155 Loss from operations Other income : Interest income 18,877 19,813 Interest expense - Other Total other income 1,548 Loss from operations before income taxes Income tax benefit 4,085,000 - Net income $ 1,796,492 $ Net income per share: Basic $ 0.18 $ Diluted $ 0.17 $ Weighted average shares - Basic 9,686,402 9..."
10/04/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/26/2019 8-K Submission of Matters to a Vote of Security Holders
08/16/2019 8-K Other Events
06/20/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Norberto Aja, Jennifer Neuman"
06/03/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "MISONIX RECEIVES U.S. FDA CLEARANCE FOR NEXUS, ITS"
05/21/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice of Proposed Settlement of Derivative Action, Settlement Hearing and Right to Appear",
"Stipulation of Settlement"
05/08/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Misonix, Inc. and Subsidiaries Condensed Consolidated Statements of Operations For the three months ended For the nine months ended March 31, March 31, 2019 2018 2019 2018 Revenues Product $ 9,556,590 $ 8,429,132 $ 29,094,208 $ 24,033,700 License — 4,010,000 — 4,010,000 Total revenue 9,556,590 12,439,132 29,094,208 28,043,700 Cost of goods sold 2,801,571 2,631,893 8,600,194 7,275,073 Gross profit 6,755,019 9,807,239 20,494,014 20,768,627 Operating expenses: Selling expenses 4,414,710 4,447,421 13,950,357 11,937,649 General and administrative expenses 2,512,510 1,925,086 8,043,078 6,879,077 Research and development expenses 1,426,483 1,199,895 3,570,468 3,058,374 Total operating expenses 8,353,703 7,572,402 25,563,903 21,875,100 income from operations 2,234,837 Other income : Interest inco..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy